Back to Journals » Biologics: Targets and Therapy » Volume 12

The role of microfluidics in protein formulations with pre-programmed functional characteristics

Authors Meng H, Deng S, You Y, Chan HF

Received 19 August 2018

Accepted for publication 17 October 2018

Published 3 December 2018 Volume 2018:12 Pages 191—197


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Doris Benbrook

Hu Meng,1,2,* Shuai Deng,1,2,* Yajing You,3 Hon Fai Chan1,2

1Institute for Tissue Engineering and Regenerative Medicine, The Chinese University of Hong Kong, Hong Kong, China; 2School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China; 3Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, China

*These authors contributed equally to this work

Abstract: Protein-based therapies hold great promise for treating many diseases. Nevertheless, the challenges of producing therapies with targeted attributes via standardized processes may hinder the development of protein formulations and clinical translation of the advanced therapies. Microfluidics represents a promising technology to develop protein formulations with pre-programmed functional characteristics, including size, morphology, and controlled drug release property. In this review, we discuss some examples of adopting microfluidics for fabricating particle- and fiber/tube-based formulations and highlight the advantages of microfluidics-assisted fabrication.

Keywords: protein therapy, microfluidics, biofabrication, controlled release

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]